Rajpal, SaurabhKahwash, RamiTong, Matthew SPaschke, KellySatoskar, Anjali AForeman, BethAllen, Larry ABhave, Nicole MGluckman, Ty JFuster, Valentin2023-03-162023-03-162022-05-31J Am Coll Cardiol. 2022 May 31;79(21):2144-2152http://hdl.handle.net/20.500.12105/15649A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.engVoRhttp://creativecommons.org/licenses/by-nc-nd/4.0/COVID-19Extracorporeal Membrane OxygenationMyocarditisArrhythmias, CardiacCritical PathwaysFemaleHumansMiddle AgedSARS-CoV-2Attribution-NonCommercial-NoDerivatives 4.0 Internacional353642107921214410.1016/j.jacc.2022.03.3461558-3597Journal of the American College of Cardiologyopen access